Inversion Space builds low-cost, high-frequency re-entry vehicles to bring cargo and resources back from space. The core idea is to provide cargo return services from low-earth orbit and beyond, working with space agencies and private companies under service contracts and partnerships. Their product works by using reusable or versatile re-entry systems to safely carry valuable materials from space back to Earth, enabling clients to shuttle resources, samples, or equipment home for analysis or use. The company differentiates itself by emphasizing affordable, high-cadence return capabilities and a service-based model rather than just selling hardware, aiming to simplify and scale the process of bringing material back from space. The overarching goal is to make returning from space as common and practical as launching to space, supporting the sustainability and growth of space operations.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$126.8M
Headquarters
Los Angeles, CA
Founded
2021
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$126.8M
Above
Industry Average
Funded Over
5 Rounds
Industry standards
Inversion introduces Zenith flight computer to steer Arc through Mach 20 reentry. The Los Angeles startup says Zenith will run Arc from Mach 20-plus reentry to parachute landing, after Ray reached orbit in 2025 but never attempted reentry. STORIES Handpicked by the editor Listen to article. Inversion introduced Zenith, its in-house flight computer for the Arc reentry spacecraft, in a thread on X on November 2nd. The Los Angeles company said Zenith "orchestrates nearly every system on Arc" from Mach 20-plus hypersonic flight through a precise, soft landing. Introducing Zenith. Its in-house designed flight computer, purpose-built for advanced reentry. From Mach 20+ hypersonic flight to a precise, soft landing, Zenith orchestrates nearly every system on Arc. Checking your browser so you can read this article. Three articles are free before registration. Already have a free or Pro account? to skip this check. When you purchase through links in its articles, RuntimeWire, Inc. may earn a small commission. This doesn't affect its editorial independence. RuntimeWire, Inc. get virtually zero search traffic. Please consider sharing this story. Signal check Noise Signal Where does this story land? Drag the dial. The startup Stay on the wire. Breaking startup & AI news, funding scoops, and launches as they happen. Follow @runtimewire on Threads and LinkedIn. Free forever - no credit card, no nagging.
Varda raises $250 million at $1.6 billion valuation to scale orbital drug manufacturing. By Thomson Reuters Sep 30, 2026 | 6:04 AM By Joey Roulette WASHINGTON, Sept 30 (Reuters) - In-space manufacturing startup Varda Space has raised $250 million in a Series D round at a $1.6 billion valuation, the company told Reuters, as it ramps up missions to produce pharmaceuticals in microgravity. El Segundo-based Varda is one of a handful of US companies building a fleet of uncrewed space capsules that can function as orbital laboratories or manufacturing platforms for products whose development in space yields better efficiencies or purities than in the gravity of Earth. The $250 million round closed this month, led by Lux Capital and Natural Capital, putting Varda's total amount raised at $598 million since its founding in 2021 by CEO and former SpaceX engineer Will Bruey and Founders Fund partner Delian Asparouhov. The company since 2023 has deployed six missions to orbit with its gumdrop-shaped free-flying W-Series capsule, with all but its fourth mission successfully re-entering from space. It plans to debut a next-generation capsule in 2030. Varda is planning to launch two capsules to space at once for the first time on Thursday, using a rideshare mission on SpaceX's Falcon 9 rocket. The two capsules are carrying hypersonic research payloads for the Pentagon and commercial customers. SpaceX is phasing out its Falcon rocket and winding down rideshare missions, alarming much of the spacecraft industry, Reuters has reported. But Varda is largely insulated from the launch squeeze - it has 28 launches with different providers booked through 2027 to 2029, Bruey said. While orbital re-entries have drawn keen interest from the Pentagon's Golden Dome missile defense efforts, Varda has bet on the pharmaceutical industry for much of its commercial operations. "The biggest milestone in the company's history is going to be right around the turn of the decade when we take one of those microgravity-enabled formulations and we inject it into a human in the clinic," Bruey said. About 70% of Varda's payload customer base for next year is government-based and the rest is commercial pharmaceutical work, Bruey said. He expects that proportion to gradually flip by 2032, underscoring the company's bet on pharmaceuticals. The company in August appointed biotechnology executive and Pfizer veteran Mikael Dolsten to its board, and about 18% of Varda's some 275 employees have pharmaceutical backgrounds, Asparouhov said. Roughly the size of a dishwasher, the company's latest pods can orbit Earth for days, then re-enter the atmosphere at some 25 times the speed of sound, with the re-entry itself offering hypersonic research capabilities for the Pentagon. Varda faces competition from SpaceX's Starfall program that debuted this year, as well as startup Inversion Space in a nascent point-to-point transportation market, where the Pentagon sees orbital space as a swift highway for shuttling military cargo anywhere in the world in roughly an hour. The business of manufacturing things in space has grown as the 2030 retirement of the International Space Station approaches. That 26-year-old orbital laboratory, managed by a group of space powers, has been a key platform for space manufacturing research in areas ranging from artificial organ growth to fiber optic cables. (Reporting by Joey Roulette; Editing by Stephen Coates)
For best search results, use the search terms first and then apply the filters. Search results are downloadable for 10,000 or fewer records.
Inversion selected by NASA to advance aerocapture technology for future interplanetary missions. Sep 10, 2026, 09:00 ET Inversion will study how its highly maneuverable reentry spacecraft, Arc, could help move aerocapture from research to flight LOS ANGELES, Sept. 10, 2026 /PRNewswire/ - Inversion today announced it has received a contract from NASA to study the use of the company's Arc spacecraft for an aerocapture demonstration, expanding the potential of Inversion's advanced reentry technologies beyond Earth. Arc is a highly maneuverable reentry spacecraft being developed for the rapid delivery of cargo from space, hypersonic testing, and national security missions that require precise, controlled flight through the atmosphere. The NASA study will explore how this capability could be applied to future interplanetary missions. Aerocapture is a simple but powerful idea: use a planet's atmosphere to slow down instead of fuel. Spacecraft arriving at another planet are traveling at tremendous speeds and traditionally must carry significant propellant to slow down and enter orbit. Aerocapture instead uses aerodynamic forces during a single controlled pass through the atmosphere to shed velocity and achieve orbital capture. Less fuel means mass savings that can enable greater flexibility in launch vehicle selection, increased science payload, and significantly shorter trip times. Despite decades of research, aerocapture has never been demonstrated in flight. NASA is working toward an Earth demonstration to mature the technology and provide the flight data needed to enable its use on potential future interplanetary missions - from Mars telecommunications satellites to exploration of Uranus and Neptune. Under the contract, Inversion will study how Arc could support the demonstration through mission design, aerodynamics, trajectory analysis, and vehicle definition. "Our Arc spacecraft was designed to precisely control the transition from space through an atmosphere at hypersonic velocities," said Justin Fiaschetti, Co-Founder and CEO of Inversion. "Aerocapture applies many of those same fundamental capabilities to an entirely new class of missions. We're excited to work with NASA to demonstrate what advanced reentry technologies can enable, both at Earth and across the solar system." The study represents a new frontier for Arc and highlights the growing range of missions enabled by advanced reentry. About Inversion Inversion is an aerospace and defense company pioneering advanced reentry technology to enable next-generation capabilities from space. By combining high-performance materials, precision aerodynamics, and mission-driven autonomy, Inversion is transforming reentry into an operational capability for an entirely new class of missions. The company's highly maneuverable reentry spacecraft, Arc, is designed for rapid global cargo delivery, hypersonic testing, and other national security missions that require precise, controlled flight through the atmosphere. Arc creates an entirely new transportation domain, unlocking unprecedented speed and global reach. Headquartered in Los Angeles, Inversion designs, manufactures, and integrates its spacecraft under one roof, enabling the company to move rapidly from concept to flight. The company is backed by leading investors including Y Combinator, Spark Capital, and Lockheed Martin Ventures, with customers across the U.S. government and commercial space industry. SOURCE Inversion
Anduril announces team for its Golden Dome space-based missile interceptor effort. 05 May 2026 09:00PM (Updated: 05 May 2026 09:04PM) Add CNA as a trusted source to help Google better understand and surface our content in search results. WASHINGTON, May 5: Defense technology company Anduril Industries on Tuesday announced its consortium to develop space-based interceptors for the U.S. Space Force, as part of the Trump administration's Golden Dome for America missile defense initiative. Unlike existing ground-based systems, the Space-Based Interceptor (SBI) program deploys weapons in orbit, enabling the U.S. military to engage and destroy threats earlier in their flight path, intercepting missiles sooner after launch. Anduril said its consortium includes Impulse Space, Inversion Space, K2 Space, Sandia National Laboratories, and Voyager Technologies, bringing together commercial space startups and established research institutions to deliver what the company described as "affordable, scalable" interceptor solutions. The Department of Defense's Space Force has awarded 12 companies contracts to develop space-based missile defense interceptor systems worth up to a combined $3.2 billion. Other recipients include Northrop Grumman, RTX's Raytheon, SpaceX, and Lockheed Martin, among others. The U.S.'s "near-peer adversaries have invested in exotic, highly maneuverable vehicles, introducing considerable challenges to protecting the U.S. homeland," Gokul Subramanian, Anduril's senior vice president of engineering, said in a statement. The goal is to demonstrate an integrated interceptor capability within the Golden Dome architecture by around 2028, adding an orbital layer to U.S. homeland defense. Golden Dome, expected to cost $185 billion, plans to expand ground-based defenses such as interceptor missiles, sensors and command-and-control systems while adding space-based elements to detect, track and potentially counter incoming threats from orbit. Golden Dome's director, Space Force General Michael Guetlein, has previously identified the SBI program as the initiative's highest-risk element, citing scalability and affordability as the central challenges. He has said directed energy weapons and next-generation artificial intelligence represent the most promising technologies for driving down cost-per-kill.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Series A
Total Funding
$126.8M
Headquarters
Los Angeles, CA
Founded
2021
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs